Atp Iii Gp, Ltd. - Net Worth and Insider Trading

Atp Iii Gp, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atp Iii Gp, Ltd. owns 4 companies in total, including Akero Therapeutics Inc (AKRO) , Stoke Therapeutics Inc (STOK) , and Avalo Therapeutics Inc (AVTX) among others .

Click here to see the complete history of Atp Iii Gp, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Atp Iii Gp, Ltd.

Ticker Comapny Transaction Date Type of Owner
AKRO Akero Therapeutics Inc 2021-06-28 10 percent owner
STOK Stoke Therapeutics Inc 2021-06-28 10 percent owner
AVTX Avalo Therapeutics Inc 2015-10-14 director & 10 percent owner
LIMIT LIMIT 2013-11-25 10 percent owner

Atp Iii Gp, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atp Iii Gp, Ltd. Ownership Network

Ownership Network List of Atp Iii Gp, Ltd.

No Data

Ownership Network Relation of Atp Iii Gp, Ltd.

Insider Network Chart

Atp Iii Gp, Ltd. Owned Company Details

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Atp Iii Gp, Ltd. is the 10 percent owner of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Development Officer Catriona Yale , director & President & CEO Andrew Cheng , and Chief Financial Officer William Richard White .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Atp Iii Gp, Ltd. made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 293,502 shares made by Andrew Cheng , a net sale of 71,282 shares made by Jonathan Young , and a net sale of 94,123 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 337,512 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 337,512 shares. During the past 18 months, 930,586 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 389,414 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akero Therapeutics Inc Insider Transactions

No Available Data

Atp Iii Gp, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Atp Iii Gp, Ltd.. You might contact Atp Iii Gp, Ltd. via mailing address: 230 Park Avenue, Suite 2800, New York Ny 10169.

Discussions on Atp Iii Gp, Ltd.

No discussions yet.